SRx Health Solutions (SRXH) Depreciation & Amortization (CF) (2010 - 2025)

SRx Health Solutions has reported Depreciation & Amortization (CF) for 14 years, with the latest figure at $50000.0 in Q3 2025.

• For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 61.29% year-over-year to $50000.0; the trailing twelve-month figure through Dec 2025 stood at $878000.0 (down 59.58% YoY), and the FY2025 full-year result was $15000.0, down 85.0% from the prior year.
• Depreciation & Amortization (CF) for Q3 2025 stood at $50000.0, down from $802000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.2 million in Q2 2024, with the low at $26000.0 in Q1 2025.
• Historically, Depreciation & Amortization (CF) has averaged $425368.4 across 5 years, with a median of $417000.0 in 2023.
• The largest YoY upside for Depreciation & Amortization (CF) was 181.71% in 2024 against a maximum downside of 92.57% in 2024.
• SRx Health Solutions' Depreciation & Amortization (CF) stood at $409000.0 in 2021, then climbed by 3.91% to $425000.0 in 2022, then decreased by 2.12% to $416000.0 in 2023, then soared by 121.15% to $920000.0 in 2024, then sank by 94.57% to $50000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $50000.0 (Q3 2025), $802000.0 (Q2 2025), and $26000.0 (Q1 2025), per Business Quant data.